Garde Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $717K | Buy |
1,853
+3
| +0.2% | +$1.11K | 0.03% | 136 |
|
|
2026
Q1 | $542K | Hold |
1,850
| – | – | 0.03% | 129 |
|
|
2025
Q4 | $649K | Hold |
1,850
| – | – | 0.04% | 131 |
|
|
2025
Q3 | $598K | Hold |
1,850
| – | – | 0.03% | 155 |
|
|
2025
Q2 | $720K | Hold |
1,850
| – | – | 0.04% | 135 |
|
|
2025
Q1 | $805K | Sell |
1,850
-6
| -0.3% | -$2.41K | 0.05% | 131 |
|
|
2024
Q4 | $685K | Hold |
1,856
| – | – | 0.05% | 120 |
|
|
2024
Q3 | $965K | Hold |
1,856
| – | – | 0.06% | 96 |
|
|
2024
Q2 | $1.01M | Sell |
1,856
-45
| -2% | -$23.8K | 0.07% | 94 |
|
|
2024
Q1 | $985K | Buy |
1,901
+27
| +1% | +$13.4K | 0.07% | 95 |
|
|
2023
Q4 | $884K | Buy |
1,874
+19
| +1% | +$8.79K | 0.07% | 97 |
|
|
2023
Q3 | $808K | Buy |
1,855
+5
| +0.3% | +$2.27K | 0.07% | 100 |
|
|
2023
Q2 | $822K | Hold |
1,850
| – | – | 0.07% | 104 |
|
|
2023
Q1 | $851K | Hold |
1,850
| – | – | 0.09% | 91 |
|
|
2022
Q4 | $949K | Hold |
1,850
| – | – | 0.11% | 79 |
|
|
2022
Q3 | $840K | Hold |
1,850
| – | – | 0.11% | 79 |
|
|
2022
Q2 | $893K | Hold |
1,850
| – | – | 0.11% | 80 |
|
|
2022
Q1 | $909K | Hold |
1,850
| – | – | 0.09% | 98 |
|
|
2021
Q4 | $858K | Hold |
1,850
| – | – | 0.08% | 98 |
|
|
2021
Q3 | $690K | Hold |
1,850
| – | – | 0.07% | 103 |
|
|
2021
Q2 | $706K | Hold |
1,850
| – | – | 0.07% | 101 |
|
|
2021
Q1 | $664K | Hold |
1,850
| – | – | 0.08% | 102 |
|
|
2020
Q4 | $594K | Hold |
1,850
| – | – | 0.07% | 104 |
|
|
2020
Q3 | $497K | Hold |
1,850
| – | – | 0.07% | 101 |
|
|
2020
Q2 | $487K | Hold |
1,850
| – | – | 0.07% | 93 |
|
|
2020
Q1 | $420K | Hold |
1,850
| – | – | 0.07% | 87 |
|
|
2019
Q4 | $559K | Hold |
1,850
| – | – | 0.08% | 85 |
|
|
2019
Q3 | $444K | Hold |
1,850
| – | – | 0.07% | 93 |
|
|
2019
Q2 | $522K | Hold |
1,850
| – | – | 0.09% | 86 |
|
|
2019
Q1 | $531K | Hold |
1,850
| – | – | 0.09% | 80 |
|
|
2018
Q4 | $486K | Hold |
1,850
| – | – | 0.09% | 112 |
|
|
2018
Q3 | $526K | Hold |
1,850
| – | – | 0.09% | 114 |
|
|
2018
Q2 | $440K | Hold |
1,850
| – | – | 0.08% | 118 |
|
|
2018
Q1 | $406K | Hold |
1,850
| – | – | 0.07% | 121 |
|
|
2017
Q4 | $416K | Hold |
1,850
| – | – | 0.08% | 115 |
|
|
2017
Q3 | $351K | Hold |
1,850
| – | – | 0.07% | 124 |
|
|
2017
Q2 | $348K | Hold |
1,850
| – | – | 0.09% | 90 |
|
|
2017
Q1 | $306K | Hold |
1,850
| – | – | 0.08% | 84 |
|
|
2016
Q4 | $266K | Buy |
+1,850
| New | +$248K | 0.08% | 91 |
|
|
2016
Q3 | – | Sell |
-1,850
| Closed | -$243K | – | 143 |
|
|
2016
Q2 | $243K | Hold |
1,850
| – | – | 0.08% | 92 |
|
|
2016
Q1 | $257K | Buy |
+1,850
| New | +$247K | 0.09% | 91 |
|
Other funds holding ELV
Garde Capital's ELV Position: Q2 2026 in Review
Garde Capital increased its Elevance Health (ELV) stake by 0.16% in Q2 2026, buying an estimated $1.11K and bringing the position to 1,853 shares worth $717K. The position accounts for 0.03% of the portfolio, ranked #136.
Garde Capital first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.01M in Q2 2024. 990 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Garde Capital held 1,853 shares of Elevance Health worth $717K as of Q2 2026.
- Garde Capital bought 3 Elevance Health shares in Q2 2026, an estimated $1.11K.
- Elevance Health made up 0.03% of Garde Capital's portfolio in Q2 2026, its #136 holding.
- Garde Capital first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
- Garde Capital's Elevance Health position peaked at $1.01M in Q2 2024.
- 990 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Garde Capital's 13F filing for Q2 2026, filed 31 Jul 2026.